COVID-19; took first dose with dinner (about 6:00PM) . About 8PM noticed a metallic taste in my mouth hat would not rinse out. Checked several possibilities like water source all negative. that left the Paxlo; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (took first dose with dinner (about 6:00PM) . About 8PM noticed a metallic taste in my mouth hat would not rinse out. Checked several possibilities like water source all negative. that left the Paxlo) and COVID-19 (COVID-19) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058h21a, 008b21a and 040a21a) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19.    The patient's past medical history included Overweight and Allergy. Concurrent medical conditions included Diabetes and Arthritis. Concomitant products included BENZONATATE from 20-May-2022 to 22-May-2022, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE (DIABETIC TUSSIN) from 22-May-2022 to 22-May-2022, GLIPIZIDE, METFORMIN HCL, CLOPIDOGREL, ATORVASTATIN, TORSEMIDE and ACETAMINOPHEN for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-May-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 22-May-2022 at 6:00 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSGEUSIA (took first dose with dinner (about 6:00PM) . About 8PM noticed a metallic taste in my mouth hat would not rinse out. Checked several possibilities like water source all negative. that left the Paxlo). On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, DYSGEUSIA (took first dose with dinner (about 6:00PM) . About 8PM noticed a metallic taste in my mouth hat would not rinse out. Checked several possibilities like water source all negative. that left the Paxlo) had not resolved and COVID-19 (COVID-19) outcome was unknown.            Checked several possibilities like water source all negative. Patient Took first dose with dinner (about 6:00PM) . About 8PM noticed a metallic taste in patient's mouth hat would not rinse out. Checked several possibilities like water source all negative. that left the Paxlovid.  Company comment- This spontaneous case concerns a 79-year-old male patient with relevant medical history of Diabetes and Overweight, who experienced the unexpected, non- serious adverse event of special interest COVID-19 occurred at an unknown time with regards to the mRNA-1273 vaccination. The patient took his first tablet of paxlovid after which he noted a metallic taste that he could not rinse out. Outcome of the events was unknown at the time of this report. The relevant medical history of Diabetes and Overweight are contributory factors to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report; Sender's Comments: This spontaneous case concerns a 79-year-old male patient with relevant medical history of Diabetes and Overweight, who experienced the unexpected, non- serious adverse event of special interest COVID-19 occurred at an unknown time with regards to the mRNA-1273 vaccination. The patient took his first tablet of paxlovid after which he noted a metallic taste that he could not rinse out. Outcome of the events was unknown at the time of this report. The relevant medical history of Diabetes and Overweight are contributory factors to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report